Diagnostic Kits/Legal uncertainty in the area of genetic diagnostic testing: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
http://www.nature.com/nbt/journal/v27/n10/abs/nbt1009-903.html [accessed Nov 2 2009]. | http://www.nature.com/nbt/journal/v27/n10/abs/nbt1009-903.html [accessed Nov 2 2009]. | ||
Legal uncertainty in the area of genetic diagnostic testing | Legal uncertainty in the area of genetic diagnostic testing<br /> | ||
Isabelle Huys1, Nele Berthels1, Gert Matthijs1 & Geertrui Van Overwalle2 | Isabelle Huys1, Nele Berthels1, Gert Matthijs1 & Geertrui Van Overwalle2 | ||
Abstract | Abstract<br> | ||
A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope. | A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope. | ||
Revision as of 18:02, 5 November 2009
Nature Biotechnology 27, 903 - 909 (2009) doi:10.1038/nbt1009-903 http://www.nature.com/nbt/journal/v27/n10/abs/nbt1009-903.html [accessed Nov 2 2009].
Legal uncertainty in the area of genetic diagnostic testing
Isabelle Huys1, Nele Berthels1, Gert Matthijs1 & Geertrui Van Overwalle2
Abstract
A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.